Cubist Systematic Strategies’s Lyell Immunopharma LYEL Stock Holding History

Cubist Systematic Strategies’s Portfolio LYEL Stock Details LYEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,438	Closed	-$64.1K	–	3579
2024 Q1	$64.1K	Sell	1,438 -1,645	-53%	-$70.4K	﹤0.01%	3341
2023 Q4	$120K	Buy	+3,083	New	+$111K	﹤0.01%	3142
2023 Q2	–	Sell	-2,473	Closed	-$117K	–	3971
2023 Q1	$117K	Buy	+2,473	New	+$132K	﹤0.01%	3410
2022 Q4	–	Sell	-1,506	Closed	-$221K	–	4440
2022 Q3	$221K	Buy	+1,506	New	+$204K	﹤0.01%	3699
2022 Q2	–	Sell	-2,440	Closed	-$246K	–	4462
2022 Q1	$246K	Sell	2,440 -5,854	-71%	-$709K	﹤0.01%	2950
2021 Q4	$1.28M	Buy	8,294 +6,261	+308%	+$1.4M	0.01%	1727
2021 Q3	$602K	Buy	2,033 +1,743	+601%	+$522K	0.01%	1901
2021 Q2	$94K	Buy	+290	New	+$95.1K	﹤0.01%	2718

Other funds holding LYEL

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WuXi AppTec Shanghai, China $19M AUM 20.22% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return